Mauna Kea Technologies today announced the appointment of Côme de La Tour du Pin as Chief Financial Officer and member of the Executive Committee.

' Côme's appointment, combined with the recent arrival of Nathalie Lecoq as Deputy Managing Director, demonstrates the Company's attraction to experienced profiles of the highest calibre', enthused Sacha Loiseau, Chairman and CEO of Mauna Kea Technologies.

Prior to joining Mauna Kea Technologies, Côme de La Tour du Pin was CFO of Lysogene, a Euronext-listed gene therapy company in clinical development, where he was in charge of financial planning and management, investor relations and fundraising.

Copyright (c) 2023 CercleFinance.com. All rights reserved.